Please assess the completion status of the following clinical trial:

Trial Title: Aspirin and Plavix Following Coronary Artery Bypass Grafting

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing coronary artery bypass grafting, with or without cardiopulmonary bypass~* Age ≥ 18~Exclusion Criteria:~* Left ventricle ejection fraction \<30%~* Emergency surgery~* Valve surgery~* Redo CABG~* Postoperative cardiogenic shock for more than 48 hours~* Postoperative bleeding or cardiac tamponade~* More than 24 hours postoperative intubation course~* Requirement of postoperative anticoagulation~* Serum creatinine \>1.4~* Contraindication to use of postoperative coronary CT scan~* Allergy or contraindication to aspirin or clopidogrel~* Inability to provide informed consent~* Pregnant or breast feeding females

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- clopidogrel (Type: ACTIVE_COMPARATOR): aspirin and clopidogrel
- sugar pill (Type: PLACEBO_COMPARATOR): aspirin and placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).